chetofen - risultati della ricerca

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

topiramat-mepha teva 300 mg lactab

mepha pharma ag - topiramatum - lactab - topiramatum 300 mg, lactosum monohydricum 133.5 mg, per amylum pregelificatum, cellulosum microcristallinum, carboxymethylamylum natricum un corrisp. sodio max. 0,8 mg, silice colloidalis anhydrica, magnesio stearas, Überzug: polydextrosum, hypromellosum, e 171, macrogolum 4000, pro compresso haze. - farmaco antiepilettico, migräneprophylaxe - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

topiramat-mepha teva 400 mg lactab

mepha pharma ag - topiramatum - lactab - topiramatum 400 mg, lactosum monohydricum 178 mg, per amylum pregelificatum, cellulosum microcristallinum, carboxymethylamylum natricum un corrisp. sodio max. 1.0 mg, silice colloidalis anhydrica, magnesio stearas, Überzug: polydextrosum, hypromellosum, e 171, macrogolum 4000, pro compresso haze. - farmaco antiepilettico, migräneprophylaxe - synthetika

Unione Europea - italiano - EMA (European Medicines Agency)

epidyolex

jazz pharmaceuticals ireland limited - il cannabidiolo - lennox gastaut syndrome; epilepsies, myoclonic - antiepilettici, - epidyolex è indicato per l'uso come terapia aggiuntiva delle crisi epilettiche associate lennox gastaut (lgs) o la sindrome di dravet (ds), in collaborazione con clobazam, per i pazienti di 2 anni di età e anziani.

Unione Europea - italiano - EMA (European Medicines Agency)

fintepla

ucb pharma s.a. - fenfluramine hydrochloride - epilepsies, myoclonic - antiepilettici, - treatment of seizures associated with dravet syndrome as an add-on therapy to other antiepileptic medicines for patients 2 years of age and older. fintepla is indicated for the treatment of seizures associated with dravet syndrome and lennox-gastaut syndrome as an add-on therapy to other anti-epileptic medicines for patients 2 years of age and older.

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

epidyolex 100 mg / 1 ml soluzione orale

jazz pharmaceuticals switzerland gmbh - cannabidiolum - soluzione orale - cannabidiolum 100 mg, ethanolum anhydricum 79 mg, sucralosum, aromatica, alcohol benzylicus 0.3 µg, sesami oleum raffinatum 736 mg ad solutionem pro 1 ml corresp. ethanolum 10 % v/v. - zusatztherapie bei krampfanfällen bei patienten ab 2 jahren mit lennox-gastaut-syndrom (lgs), dravet-syndrom (ds) oder der tuberösen sklerose (tsc) - synthetika